Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Leonard Braden Michael sold 300,000 Aclaris Therapeutics, Inc. shares (Form 4)
Traded Apr 23, 2026 · Filed Apr 27, 2026
On Apr 23, 2026, Leonard Braden Michael (10% owner) sold 300,000 Aclaris Therapeutics, Inc. shares at US$4.53 for US$1.36M, leaving 13,950,000 shares. Filed Apr 27, 2026 (Form 4).
- Sold
- 300,000 shares
- Price
- US$4.53
- Value
- US$1.36M
- Holding after
- 13,950,000 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock | Sale | 300,000 | US$4.53 | 13,950,000 | Indirect |
Source
Related
- Aclaris Therapeutics, Inc.
- Leonard Braden Michael
- Aclaris Therapeutics, Inc. shareholders
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Sep 21, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Kolbeck Roland Wilhelm · Aug 4, 2026
- Form 4 · Schiff Andrew N · Jun 8, 2026
- Form 4 · Molineaux Christopher P. · Jun 8, 2026